Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$953M |
| 2 |
NVIDIA
NVDA
|
+$784M |
| 3 |
Meta Platforms (Facebook)
META
|
+$753M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$316M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$315M |
Top Sells
| 1 |
Amazon
AMZN
|
+$1.17B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$506M |
| 4 |
Abbott
ABT
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$325M |
Sector Composition
| 1 | Technology | 20.29% |
| 2 | Healthcare | 16.94% |
| 3 | Consumer Discretionary | 12.83% |
| 4 | Consumer Staples | 9.16% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Peraso
PRSO
$7.66M
| $124K | ﹤0.01% |
6,263
+5,575
| +810% | +$110K |
|
3427
Focus Universal
FCUV
$20M
| $123K | ﹤0.01% |
8,071
+6,831
| +551% | +$104K |
|
3428
Mexco Energy
MXC
$17.7M
| $123K | ﹤0.01% |
10,200
-1,200
| -11% | -$14.5K |
|
3429
Oramed Pharmaceuticals
ORMP
$99.6M
| $121K | ﹤0.01% |
33,700
+21,800
| +183% | +$78.3K |
|
|
PPTA
3430
Perpetua Resources
PPTA
$1.85B
| $121K | ﹤0.01% |
32,886
+18,786
| +133% | +$69.1K |
|
|
AIM
3431
AIM ImmunoTech Inc.
AIM
$7.04M
| $120K | ﹤0.01% |
1,788
+101
| +6% | +$6.78K |
|
3432
Antelope Enterprise Holdings
AEHL
$20.4M
| $119K | ﹤0.01% |
346
+285
| +467% | +$98K |
|
3433
OptimumBank Holdings
OPHC
$49.9M
| $119K | ﹤0.01% |
41,300
-3,900
| -9% | -$11.2K |
|
|
QNTM
3434
Quantum Biopharma Ltd. Class B Subordinate Voting Shares
QNTM
$61.1M
| $118K | ﹤0.01% |
1,578
+516
| +49% | +$38.6K |
|
3435
Aptevo Therapeutics
APVO
$4.93M
| $117K | ﹤0.01% |
2
| – | – |
|
3436
Data Storage Corp
DTST
$33.1M
| $117K | ﹤0.01% |
+50,401
| New | +$117K |
|
3437
Geospace Technologies
GEOS
$212M
| $117K | ﹤0.01% |
15,100
-10,600
| -41% | -$82.1K |
|
3438
Boxlight
BOXL
$4.65M
| $116K | ﹤0.01% |
10,469
+2,212
| +27% | +$24.5K |
|
3439
Carver Bancorp
CARV
$11.2M
| $116K | ﹤0.01% |
43,568
-7,208
| -14% | -$19.2K |
|
|
CLEU
3440
DELISTED
China Liberal Education Holdings
CLEU
| $116K | ﹤0.01% |
6
-3
| -33% | -$58K |
|
3441
PDS Biotechnology
PDSB
$55.5M
| $115K | ﹤0.01% |
22,862
-342,875
| -94% | -$1.72M |
|
|
LBPH
3442
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $115K | ﹤0.01% |
+15,700
| New | +$115K |
|
3443
DSS Inc
DSS
$11.9M
| $115K | ﹤0.01% |
15,988
+594
| +4% | +$4.27K |
|
3444
Vor Biopharma
VOR
$229M
| $112K | ﹤0.01% |
36,400
+8,000
| +28% | +$24.6K |
|
|
ZEPP
3445
Zepp Health
ZEPP
$719M
| $112K | ﹤0.01% |
24,550
-350
| -1% | -$1.6K |
|
3446
Bridgeline Digital
BLIN
$16.1M
| $111K | ﹤0.01% |
94,188
-49,656
| -35% | -$58.5K |
|
3447
IZEA Worldwide
IZEA
$60.4M
| $111K | ﹤0.01% |
46,025
+10,725
| +30% | +$25.9K |
|
|
SKE
3448
Skeena Resources
SKE
$2.01B
| $111K | ﹤0.01% |
+23,003
| New | +$111K |
|
3449
Dominari Holdings
DOMH
$108M
| $109K | ﹤0.01% |
37,326
+2,400
| +7% | +$7.01K |
|
|
CNTB
3450
Connect Biopharma Holdings Limited Ordinary Shares
CNTB
$90.8M
| $108K | ﹤0.01% |
95,500
+6,400
| +7% | +$7.24K |
|